Skip to main content

Table 2 Clinical and laboratory findings in the 2000–2004 group and the 2010–2014 group (n = 615)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

  2000–2004 (n = 284) 2010–2014 (n = 331) P
Age (month) 30.5 ± 22.3 29.1 ± 20.5 0.433
Sex (M/F) 168/116 207/124 0.408
Fever (day)
 Preadmission 4.9 ± 2.1 4.2 ± 1.5 < 0.001
 Total 7.2 ± 3.2 6.4 ± 2.0 < 0.001
Hospitalization (d) 8.5 ± 4.1 6.1 ± 2.4 < 0.001
Incomplete KD, n (%) 75 (26.4) 153 (46.2) < 0.001
Repeated IVIG, n (%) 26 (9.2) 33 (10) 0.784
CALs, n (%) 67 (23.6) 52 (15.7) 0.014
Ectasia 61 (21.5) 50 (15.1) 0.046
Aneurysm 6 (2.1) 2 (0.6) 0.153
WBC (/mm3) 15,200 ± 5100 14,900 ± 5200 0.476
 Neutrophil (%) 63.4 ± 16.5 65 ± 14.8 0.226
 Lymphocyte (%) 23.4 ± 13 24.7 ± 12.2 0.197
Hemoglobin (g/dL) 10.8 ± 0.9 11.5 ± 0.9 < 0.001
Platelet (/mm3) 318 ± 159 336 ± 98 0.012
Platelet, follow-up 513 ± 207 431 ± 155 < 0.001
CRP (mg/dL) 10.4 ± 6.8 8.8 ± 5.3 0.002
ESR (mm/h) 57 ± 23 74 ± 32 < 0.001
Total protein (g/dL) 6.5 ± 0.7 6.5 ± 0.6 0.368
Albumin (g/dL) 3.5 ± 0.4 3.8 ± 0.5 < 0.001
AST (IU/L) 77 ± 145 62 ± 75 0.128
ALT (IU/L) 111 ± 146 118 ± 174 0.625
ALT <40 IU, n (%) 131 (46.2) 156 (47.1) 0.654
ALT 41–99 IU, n (%) 63 (22.2) 68 (20.5) 0.684
ALT >100 IU, n (%) 90 (31.6) 107 (32.3) 0.863
  1. Values are mean ± SD or n (%). Abbreviations as in Table 1